medium dosage inactivated SARS-CoV-2 vaccine

BIOLOGICAL2 trials

Sponsors

Beijing Minhai Biotechnology Co., Ltd

Conditions

COVID-19

Phase 1

A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)

Beijing Minhai Biotechnology Co., LtdCOVID-19

Start: 2020-10-07End: 2022-02-28Updated: 2021-02-17

Phase 2

A Study to Evaluate Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)

Beijing Minhai Biotechnology Co., LtdCOVID-19

Start: 2020-10-27End: 2022-02-28Updated: 2021-02-17